Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
A bit of MSC background from the MS Society:
https://www.mssociety.org.uk/research/explore-our-research/emerging-research-and-treatments/stem-cells/mesenchymal-stem-cell-therapy
Onwards Avacta.
Excellent find, gadgie.
Looks like Stonebridge have now invested twice in Affyxell.
There's more in theses MSC therapies than we know I reckon and the manufacturer is lined up and also invested.
Sounds promising.
Onwards Avacta.
MCB,
Not sure that LSE accurately display buys and sells.
I also thought the SP would be going up as the trades came in but what would any of us know?
Can't be shenigans as this is always dismissed as nonsense.
As soon as we know that AVA600 improves the therapeutic index of doxorubicin we will see this go upwards without a doubt.
Onwards Avacta.
https://aacrjournals.org/cancerres/article/82/12_Supplement/1815/700880
Some interesting toxicity comparisons between AVA6000 and doxorubicin.
Onwards Avacta.
https://www.withpower.com/trial/phase-1-sarcoma-6-2021-6f477
This must be DE (in my opinion).
We know that this is "up to three" tumour types and that pancreatic was the first and we also know that Glasgow has previously asked for head and neck volunteers and is now asking for breast cancer volunteers.
I may be joining up too many dots but for all those with any of the above this would be amazing news.
Onwards Avacta.
https://www.withpower.com/trial/phase-1-sarcoma-6-2021-6f477
Pretty sure this said "head and neck" the other week.
First I have seen about breast cancer.
Happy to be corrected.
Onwards Avacta.
Not a bad article about FAP:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586189/
Even mentions pro drugs.
Onwards Avacta.
For some reason I can't get a link but if you type FAPI PET imaging into Google and scroll down a little there is a pdf from Avacta last year covering TMAC etcetera, which may help and is very interesting anyway.
All the best.
Onwards Avacta.
... another one here:
https://www.biopharminternational.com/view/lg-chem-renews-license-with-avacta-for-ind-studies
Onwards Avacta.
https://www.cambridgenetwork.co.uk/news/affyxell-successfully-completes-funding-round
I think we sometimes forget about the multiple other shots that Avacta has on goal and some go off on pointless tangents of course. You wonder why but such is life.
Just my opinion of course.
Onwards Avacta.